Digital Therapeutics Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Digital Therapeutics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.5% during the forecast period.
This report presents the market size and development trends by detailing the Digital Therapeutics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Digital Therapeutics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Digital Therapeutics industry and will help you to build a panoramic view of the industrial development.
Digital Therapeutics Market, By Type:
Software
Devices
Digital Therapeutics Market, By Application:
Patients
Employers
Healthcare Providers
Caregivers
Payers
Pharmaceuticals
Others
Some of the leading players are as follows:
Medisafe
GE Healthcare
Doximity
Siemens
Noom
Evolent Health
Propeller Health
Ginger.Io
Mango Health
Pear Therapeutics
Adheretech
Omada Health
Proteus Digital Health
2morrow
Canary Health
Livongo Health
Medtronic
WellDoc
Twine Health
Nanobiosym
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Digital Therapeutics Market: Technology Type Analysis
-
4.1 Digital Therapeutics Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Digital Therapeutics Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Software
4.3.2 Devices
5 Digital Therapeutics Market: Product Analysis
-
5.1 Digital Therapeutics Product Market Share Analysis, 2018 & 2026
-
5.2 Digital Therapeutics Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Digital Therapeutics Market: Application Analysis
-
6.1 Digital Therapeutics Application Market Share Analysis, 2018 & 2026
-
6.2 Digital Therapeutics Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Patients
6.3.2 Employers
6.3.3 Healthcare Providers
6.3.4 Caregivers
6.3.5 Payers
6.3.6 Pharmaceuticals
6.3.7 Others
7 Digital Therapeutics Market: Regional Analysis
-
7.1 Digital Therapeutics Regional Market Share Analysis, 2018 & 2026
-
7.2 Digital Therapeutics Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Medisafe
9.1.1 Medisafe Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 GE Healthcare
9.2.1 GE Healthcare Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Doximity
9.3.1 Doximity Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Siemens
9.4.1 Siemens Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Noom
9.5.1 Noom Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Evolent Health
9.6.1 Evolent Health Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Propeller Health
9.7.1 Propeller Health Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Ginger.Io
9.8.1 Ginger.Io Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Mango Health
9.9.1 Mango Health Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Pear Therapeutics
9.10.1 Pear Therapeutics Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Adheretech
9.11.1 Adheretech Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Omada Health
9.12.1 Omada Health Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Proteus Digital Health
9.13.1 Proteus Digital Health Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 2morrow
9.14.1 2morrow Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Canary Health
9.15.1 Canary Health Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Livongo Health
9.16.1 Livongo Health Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Medtronic
9.17.1 Medtronic Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 WellDoc
9.18.1 WellDoc Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 Twine Health
9.19.1 Twine Health Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
9.20 Nanobiosym
9.20.1 Nanobiosym Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis
The List of Tables and Figures (Totals 107 Figures and 144 Tables)
Figure Software Digital Therapeutics market, 2015 - 2026 (USD Million)
Figure Devices Digital Therapeutics market, 2015 - 2026 (USD Million)
Figure Patients market, 2015 - 2026 (USD Million)
Figure Employers market, 2015 - 2026 (USD Million)
Figure Healthcare Providers market, 2015 - 2026 (USD Million)
Figure Caregivers market, 2015 - 2026 (USD Million)
Figure Payers market, 2015 - 2026 (USD Million)
Figure Pharmaceuticals market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Digital Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table North America Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table North America Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table North America Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Canada Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Canada Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Europe Digital Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table Europe Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Europe Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Europe Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Germany Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Germany Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table France Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table France Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Italy Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Italy Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Spain Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Spain Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Digital Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table China Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table China Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Japan Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Japan Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table India Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table India Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Digital Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table MEA Digital Therapeutics market, by country, 2015 - 2026 (USD Million)
-
Table MEA Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table MEA Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table MEA Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Digital Therapeutics market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Digital Therapeutics market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Digital Therapeutics market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Medisafe Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Doximity Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Siemens Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Noom Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Evolent Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Propeller Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ginger.Io Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mango Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pear Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Adheretech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Omada Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Proteus Digital Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table 2morrow Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Canary Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Livongo Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medtronic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table WellDoc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Twine Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nanobiosym Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis